The STUDIA UNIVERSITATIS BABEŞ-BOLYAI issue article summary

The summary of the selected article appears at the bottom of the page. In order to get back to the contents of the issue this article belongs to you have to access the link from the title. In order to see all the articles of the archive which have as author/co-author one of the authors mentioned below, you have to access the link from the author's name.

  
       
         
    STUDIA CHEMIA - Issue no. 3 / 2023  
         
  Article:   TOXICITY OF HEMOGLOBIN DERIVATIZED WITH OXIDIZED ADENOSINE TRIPHOSPHATE AGAINST TUMORAL HUMAN CELLS.

Authors:  EVA FISHER-FODOR, KINGA SZABO , FLORINA SCURTU, MARIA LEHENE, RADU SILAGHI-DUMITRESCU. 		 
       
         
  Abstract:  
DOI: 10.24193/subbchem.2023.3.10

Published Online: 2023-09-30
Published Print: 2023-09-30
pp. 153-160

VIEW PDF

FULL PDF

Adenosine triphosphate (ATP) has a high affinity for the organic phosphate binding site of hemoglobin (Hb), affecting the affinity for oxygen. Periodate-oxidized-ATP (oATP) behaves as an affinity tag for several enzymes that use ATP as a substrate and has the ability to form intermolecular aldimine bonds by reaction with free amino groups on proteins. Due to its unique structure, oATP has been used to produce structural and functional modifications of Hb to obtain a compound with a low affinity for oxygen that could be used as a blood substitute. However, the oATP-Hb derivative was shown to present a notable increase in pro-oxidative reactivity compared to Hb in vitro, and accordingly exhibited toxicity in in vivo studies. This pro-oxidant reactivity was alleviated by crosslinking Hb with bovine serum albumin (BSA) in an oATP-Hb-BSA copolymer. We now show that oATP and oATP-Hb-BSA display high-affinity toxicity towards cancer cells, and may hence deserve further investigation as adjuvants in anti-cancer therapy.

Keywords: hemoglobin, cells, oATP, blood substitute, cancer 		 
         
     
         
         
      Back to previous page